First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.44 USD -7.11% Market Closed
Updated: Apr 26, 2024

ADC Therapeutics SA
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ADC Therapeutics SA
Other Current Assets Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Other Current Assets
$16.3m
CAGR 3-Years
18%
CAGR 5-Years
59%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Other Current Assets
CHf6.4m
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Other Current Assets
$14.4m
CAGR 3-Years
-18%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Other Current Assets
CHf7.7m
CAGR 3-Years
42%
CAGR 5-Years
35%
CAGR 10-Years
4%
Idorsia Ltd
SIX:IDIA
Other Current Assets
CHf34.9m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Other Current Assets
CHf513k
CAGR 3-Years
-43%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Other Current Assets?
Other Current Assets
16.3m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Other Current Assets amounts to 16.3m USD.

What is ADC Therapeutics SA's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
59%

Over the last year, the Other Current Assets growth was -39%. The average annual Other Current Assets growth rates for ADC Therapeutics SA have been 18% over the past three years , 59% over the past five years .